Arun Rajasekaran: Demonstrating an Association Between Serum Anti-PLA2R Ab and Thrombosis Risk
Arun Rajasekaran, Nephrologist at Renal Medicine Associates, shared a post on X about a recent article he and his colleagues co-authored, published in Glamerular Diseases, adding:
“Our publication evaluating serum phospholipase A2 receptor antibody’s association with thromboembolic risk in membranous nephropathy is out.
This systematic review and meta-analysis is amongst the 1st to demonstrate an association between serum anti-PLA2R Ab and thrombosis risk”
Title: Serum Phospholipase A2 Receptor Antibody Is Associated with Thrombogenesis in Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis
Authors: Paula Dibo, Henrique Alexsander Ferreira Neves, Raghunandan Konda, Alanis Yael Szyferman, Federico Napoli, Ifunanya Peculiar Nnajiofor, Clara Campoverde, Saeed Razaq, Arun Rajasekaran
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention